Newsletter of MEDICA | View in browser | Deutsch | Print
Header of MEDICA Newsletter

Bypass from the laboratory

Dear Sir or Madam,

Researchers have been wanting to create tissue in the laboratory for a long time. They aim to make medicine independent from donated tissue and organs. But until now, this endeavor has not been successful because many kinds of tissue are too complex. Researchers from the Leibniz University Hanover now want to create human vascular grafts in a bioreactor. Read more about this in our current interview.

Have a nice week,

Timo Roth
Editorial team MEDICA-tradefair.com
image: 12 - 15 November 2018, MEDICA - World Forum for Medicine in Düsseldorf

Table of Contents

Topic of the Month: Hospitalar and Meditech
Interview: bypass from the bioreactor
Newsletter Service
RSS Service
Newsletter Archive

Hospitalar and Meditech: South America's medical technology trade fairs

Topic of the Month

Image: three-dimensional map of South America with pictograms of people on it; Copyright: panthermedia.net/Kiyoshi Takahase Segundo
The medical technology trade fairs Hospitalar and Meditech could not be more different. While one has been the leading medical trade fair in America for 25 years, the other only exists for 10 years now. But the two trade fairs have one thing in common: their aim is to boost the South American medical market and thus improve the country's healthcare sector.
Read more in our Topic of the Month:
Hospitalar and Meditech: South America's medical technology trade fairs
South America – Medical technology in Brazil and Colombia

Research & Technology

Eating more fish could prevent Parkinson's disease

A new study from Chalmers University of Technology, Sweden, shines more light on the link between consumption of fish and better long-term neurological health. Parvalbumin, a protein found in great quantities in several different fish species, has been shown to help prevent the formation of certain protein structures closely associated with Parkinson's disease.
read more
To top

Research & Technology

Cancer: Tumor transition states

Tumor heterogeneity describes the differences between different cells within a given tumor. These differences have major implications for the diagnosis, prognosis, and therapy of cancer patients. Different mechanisms have been proposed to account for tumor heterogeneity such as epithelial to mesenchymal transition (EMT).
read more
To top

Research & Technology

Cancer drug observed at work

Using a Raman microscope, researchers at Ruhr-Universität Bochum have studied at which targets the cancer drug Neratinib binds in cells and how its chemical structure changes. Compared with other techniques, this method offers a considerable advantage, as it is not necessary to apply a label to the drug that would indicate its distribution indirectly; rather, the drug itself can be monitored.
read more
To top

Tissue engineering: how to grow a bypass

Interview

Image: Two hands are holding a tubular frame that is carrying a glistening wet, white tube; Copyright: Leibniz University of Hanover/Institute of Technical Chemistry
A bypass is a complicated structure. It is either made of synthetic materials that can cause blood clots and infections or created by using the patient’s veins. However, the latter often does not yield adequate material. A newly developed bioreactor could solve this problem in the future. It is designed to tissue engineer vascular grafts by using the body's own material.
Read the interview here:
Tissue engineering: how to grow a bypass
All interviews at MEDICA-tradefair.com
To top

Public Health & Associations

European Immunization Week 2018 – the right to be protected or the duty to protect?

The European Immunization Week's general slogan "Prevent. Protect. Immunize" is more relevant than ever in times of globalization and migration. It is a political and structural challenge to give as many people as possible access to vaccination. But even the best care is of no use if the individual does not recognize his or her duty to society.
read more
To top

Newsletter Service

You like our newsletter? Then please recommend us: Forward this newsletter or the link www.MEDICA.de/news_login_2 to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to redaktion@medica.de.
To top
Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 (0)211 / 4560-01
Fax: +49 (0)211 / 4560-668
www.messe-duesseldorf.de
info@messe-duesseldorf.de

County Court Düsseldorf HRB 63

Board of Managing Directors: Werner M. Dornscheidt (Chairman), Hans Werner Reinhard, Joachim Schäfer, Bernhard Stempfle

Chairman of Supervisory Board: Mayor Thomas Geisel

Facebook Twitter LinkedIn YouTube

Should you no longer wish to receive our newsletter, please click here.